Immune mediator expression signatures are associated with improved outcome in ovarian carcinoma. (2019)
Attributed to:
Preclinical efficacy of an antibody of the IgE class against a melanoma-associated antigen
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1080/2162402x.2019.1593811
PubMed Identifier: 31069161
Publication URI: http://europepmc.org/abstract/MED/31069161
Type: Journal Article/Review
Volume: 8
Parent Publication: Oncoimmunology
Issue: 6
ISSN: 2162-4011